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Nanostructured materials exhibit unique and useful properties which can be 
applied to various areas. In particular, imaging science and technology has 
actively been adapting nanoparticles as imaging agents and tracking probes. 
Advances in imaging techniques allow for accurate detection of early-stage of 
cancer and targeted therapies based on the cancer-specific markers. However, 
among all the imaging modalities, no single modality is perfect to meet all the 
requirements in medical applications. Each imaging modality has certain 
advantages as well as limitations, and the choice for an imaging modality, or 
combination of techniques, is determined by the specific biological questions 
being asked. Developing dual modal imaging probes and combining the 
advantages of these modalities can offer synergistic advantages in providing 
more valuable diagnostic information and treatment strategies.   
Hence, we demonstrated that multimodal imaging nanoparticle combined 
with optical imaging and nuclear imaging has merit for potential imaging of 
various biological targets and process with high sensitivity and specificity 
without the tissue penetrating limit. It is based on the use of fluorescent dye-




imaging contrast agent. The silica NPs have the advantages that their surface 
can be easily modified according to applications. Furthermore, we have also 
conjugated the well-known PET imaging probe 68Ga and targeting moiety, 
Herceptin on the F-silica NPs, which will allow specific targeted bio imaging 
independent of tissue depth. This multifunctional nanoprobe is capable of 
optical imaging which is also detectable by PET after cell targeting.  
Moreover, in order to impart stealth properties to the F-silica NPs, we 
conjugated heterobifunciotnal PEG on F-silica NPs. Also we confirmed the 
effect of PEG chain length on the resulting particle size, surface charge and 
68Ga labeling efficiency of F-silica NPs. The method of using PEG 10,000 on 
1 v/v% APTS modified F-silica NPs was effective surface modification 
strategy for effective 68Ga labeling. Therefore, functionalized F-silica NPs are 
promising candidate as an efficient imaging probe of PET technique. We will 
further discuss the strategy of ligand conjugation for targeting without losing 
its functionality after attachment to the F-silica NPs. 
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Chapter 1. Introduction 
 
1.1.  Imaging Modalities for Bio Imaging  
 
 Bio imaging has become an indispensable tool in biomedical 
research. Advances in imaging techniques allow accurate mapping of 
lesions improving preoperative planning and patient selection. Also it 
attempts to characterize and quantify biological processes at the 
cellular and subcellular level in intact living subjects. A number of 
molecular imaging techniques, such as optical imaging (OI), magnetic 
resonance imaging (MRI), ultrasound imaging (USI), positron 
emission tomography (PET), and others have been reported for 
imaging of in vitro and in vivo biological specimens. These imaging 
system provides anatomical and physiological information.1 
 OI is a relatively low-cost, noninvasive and extensively used imaging 
technique, in that light is taken as the most readily available and 
versatile imaging radiation source in nature. Fluorescence imaging 
and bioluminescence imaging are two major techniques in OI to 
analyze the propagation of nonionizing radiation, light photons 
through a medium such as tissue.2 Today, tomographic reconstruction 
of infrared photons, spectral unmixing, image fusion and multichannel 
imaging have become routine, and several preclinical and clinical 
imaging systems are commercially available.3      





suitable for providing spatial information and thus capable of 
identifying anatomical location of tumor. CT is based on the 
exploitation of X-ray scanning, its attenuation in tissues and computed 
image reconstruction to obtain morphologic and vascular information 
within the body. MRI is a noninvasive medical diagnostic technique. 
MRI has high spatial resolution of image and combines morphological 
and functional imaging. However the sensitivity of these techniques is 
not significantly high enough for detecting abnormalities at the 
cellular level. 
On the other hand, PET provides high target sensitivity and three-
dimensional images of various biochemical functions in human body. 
But this modality suffers from poor spatial resolution.4  
Among all the molecular imaging modalities, no single modality is 
perfect to meet all the requirements in medical applications. Each 
imaging modality has certain advantages as well as limitations, and 
the choice for an imaging modality, or combination of the techniques, 
is determined by the specific biological questions being asked. 
Developing dual modal imaging probes and combining the advantages 
of these modalities can offer synergistic advantages in providing more 


























1.2. Multifunctional Nanoparticles (NPs) for 
Multimodal Imaging 
 
Nanostructured materials exhibit unique and useful unique electric, 
optical, and magnetic properties which can be applied to various areas. 
In particular, imaging science and technology has actively been 
adapting nanoparticles as imaging agents and tracking probes. Due to 
the large surface area of nanoparticles and inherent functionalities, 
structural modifications are readily achived to alter their 
pharmacokinetics, their vascular circulation life-time, improve their 
extravasation capacity, and ensure an enhanced biodistribution in vivo. 
Many nanoparticle-based structures are currently under investigation 
and some well-studied nanoparticles include silica nanoparticles, 
quantum dots, iron oxides, dendrimers, nanotubes and so on.7 For 
example, proteic fluorophores and organic/inorganic fluorescent dyes 
are popular imaging agents. Besides, quantum dots and silica 
nanoparticles with fluorescent shell structure have also been employed 
as fluorescent imaging agents in vitro and in vivo. Commonly used 
contrast agents for MRI include paramagnetic complex, paramagnetic 
ion nanoparticles, superparamagnetic iron oxide nanoparticles.8  
Gold NP-based contrast agents have drawn substantial interest in 
vivo X-ray imaging for the last decade. These particles have shown to 
have in vivo functionality as CT contrast agents for cancer. Gold NPs 





PET and SPECT are twe major type of radionuclide imaging 
modalities. Various radionuclides, such as 16F, 64Cu and 68Ga (for 
PET) and 125I and 111In (for SPECT) can be applied as radioisotopes, 
respectively. 9 
Various nanopaticles are used as imaging probes. Although it is 
challenging to integrate dual or multimodal imaging properties into 
single probe, this concept is probably the most promising approach to 
overcome current drawbacks in one single imaging modality. 
Nowadays, many nanoparticles-based dual or multimodal imaging 















1.3. Silica Nanoparticles-based Imaging Probe 
  
 Silica based nanoparticles(NPs) have been developed for the 
purposes of bioimaging and biosensing. Silica is a good material for 
this work because it is easy to host imaging agents such as fluorescent 
dyes, metal ions, and drugs. Silica matrix is transparent and allows for 
excitation and emission light to pass through efficiently. Encapsulation 
by silica also provides enhanced photostability for optical agents.10 
The surface of silica particles can be modified easily to attach bio 
molecules; it is water dispersible, resistant to microbes, biocompatible 
and resistant to swelling in various solvents. These characteristics of 
silica have led to its use as several multifunctional nanoparticles. 
These silica NPs are used in fluorescence imaging as dye-doped silica 
NPs. Commonly, rapid photobleaching is one of the problems with 
organic dyes. Encapsulation of dyes in a silica matrix is one method 
presently used to maximize both in vitro and in vivo stability. This 
minimizes oxygen access, increases chemical stability, photostability 
(suitable of imaging studies at cellular, subcellular, and even 
molecular level) and allows surface modification to enhance 
hydrophilic character and to attach biomolecules.11 Therefore, silica 
NPs can improve the ability of fluorescence dyes to perform cellular 
imaging and targeting. 
 Meanwhile, the development of targeted contrast agents for bio 





events and process in both living and nonviable systems with 
improved detection limits, imaging modalities and engineered 
biomarker functionality.12 There is a need, above all, to develop novel 
NPs for accurate detection of early-stage of cancer and for targeted 
therapies based on the cancer-specific markers, which could lead to 
personalized medicine. Recent advances in nanomaterials have great 
potential targeting imaging probe. Several ligands with therapeutic 
and diagnostic properties can be incorporated on the NP’s surface. 
Multivalent targeting significantly increases the binding affinity of a 
NPs toward a target cell.13 The targeted delivery of nanomaterials can 
overcome problems associated with conventional anticancer drugs, 
including insolubility in aqueous conditions, rapid clearance, and a 
lack of selectivity, resulting in nonspecific toxicity toward normal 
cells.14 The silica NPs are optically transparent, water dispersible, 
biologically inert, nontoxic, and have well established conjugation 
strategies to modify the surface using silane chemistry. 15 Especially, 
the advanced features of silica NP probes can afford a substantial 
advantage in detection of single molecule, bioimaging and extraction 











1.4. Surface Engineering of Nanoparticles for in vivo 
Imaging   
 
NPs can be used as powerful probes for in vivo imaging in medical 
and biological diagnostics. Several NP-based contrast agents have 
been developed to overcome the issues of conventional contrast agents. 
However, most of the currently developed NP probes are limited to a 
single imaging modality. Target specificity, noninvasiveness, high 
spatial resolution, 3-D tomography and real-time imaging are the 
important requirements for NPs to be used in biomedical application. 
But, a single imaging modality alone can not possess all the necessary 
requirements.16 Therefore, multimodal imaging strategy can 
compensate for the weakness of single imaging modality. For 
multimodal NPs fabrication, the integration of multi-components into 
a NP can be achieved by modifying the NP’s surface, and then 
combining different modalities into a single system. The surface of 
NPs can accommodate a large number or a wide range of surface 
functional groups allowing conjugation of diagnostic and therapeutic 











1.5. Research Objective  
 
 A current approach to overcome the limitations imposed by a single 
imaging modality is to combine two or more modalities into a single 
NP. For example, a core NP could be linked to a specific targeting 
ligand that recognizes their target cells. Simultaneously, the same 
particle can be coupled with an imaging agent for multimodal imaging 
or a moiety to evaluate the therapeutic efficacy of a drug or a 
therapeutic agent. In short, the function of the multifunctional 
nanoparticle depends on the component attached.18 Hence, we expect 
that multimodal NPs combined with optical imaging and nuclear 
imaging have merit for potentially imaging of various biological targets 
and process with high sensitivity and specificity without the tissue 
penetrating limit. It is based on the use of fluorescent dye-doped silica 
NPs as the core material for optical imaging. The silica NPs have the 
advantages that their surface can be easily modified according to 
applications. These characteristics of silica NPs have provided an 
efficient platform for multifunctional nanoprobes. Furthermore, we 
have also conjugated the well-known PET imaging probe 68Ga and 
targeting moiety, Herceptin to the F-silica NPs, which will allow 
specific targeting and bio imaging. For this purpose, we have designed 
a conjugation method of radioactive 68Ga chelator, NOTA on F-silica 
NPs. Also, Herceptin, antibody of HER2, was chosen as the targeting 





has been observed on the plasma membrane of tumors, in particular 
breast and ovarian cancers. Herceptin conjugated multifunctional Si 
NPs can be used as a HER2-targeting diagnostic imaging probe. This 
multifunctional nanoprobe is capable of optical imaging and detectable 
by PET after cell targeting. Furthermore, in order to impart stealth 
properties to the NPs, heterobifunciotnal PEG was conjugated to F-
silica NPs. PEG is commonly used to achieve stealth properties, due to 
its hydrophilicity, flexibility, which help the NPs to be dispersed and to 
increase their blood circulation times.19-20  
 We hope that F-silica NP based multifunctional imaging probes for 





















2.1.1.  Material 
 
3-(Aminopropyl)triethoxysilane (APTS), Rhodamine B 
isothiocyanate (RBITC), triton X-100, tetraethyorthosilicate (TEOS), 
ethylenediaminetetraacetic acid (EDTA), 2-mercaptoethylamine˙HCl 
(2-MEA), (3-trihydroxysilyl)propyl methyl phosphonate monosodium 
salt (THPMP, 24 wt% solution in water) were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Cyclohexane and n-hexanol were 
bought from Junsei Chemicals (Tokyo, Japan). Ammonium hydroxide 
(NH4OH, 27%), ethanol, N-methyl-2-pyrrolidone (NMP), 
dimethylformaldehyde (DMF), piperidine were purchased from Dae-
Jung Chemicals (Siheung, Korea). Fmoc-Lysine was bought from 
Bachem (Torrance, USA). (Benzotriazol-1-yloxy)-tris(dimethyl- 
amino)-phosphonium hexafluorophosphate (BOP), 1-hydroxybenzo- 
triazole (HOBt) were purchased from Bead Tech (Seoul, Korea). N,N-
Diisopropyl ethylamine (DIEA) was bought from Alfa Aesar 
(Massachusetts, USA). Fmoc protected polyethylene glycol active 
ester (MW 10000) was purchased from Creative PEGWorks (Winston 






1-carboxylate sodium salt (sulfo-SMCC) was bought from Thermo 
scientific (IL, USA). Trastuzumab (Herceptin) was purchased from 




Transmission electron microscope (TEM) images were obtained 
using Energy-Filtering transmission electron microscope (Carl Zeiss, 
LIBRA 120, Germany). The particle size was measured using a 
particle size analyzer, Zetasizer Nano S (Malvern Instruments, 
Malvern, UK). The zeta potential was measured by using a Zetasizer 
Nano Z (Malvern Instruments). TGA analysis was performed by using 
Thermo Gravimetric Analyzer (TGA; TA Instruments, Q-5000 IR, 
USA). 68Ga/68Ga generator was purchased from Cyclotron (Obninsk, 
Russia). Instant TLC-silica gel (ITLC-SG) plates were bought from 
Pall (USA). Radio-thin layer chromatography (TLC) was counted 
using a Bio-Scan AR-2000 System imaging scanner (Bioscan, USA) . 
 Fmoc quantification test was followed by UV/visible spectro- 








2.2. Synthesis of F-silica NPs 
 
2.2.1. Preparation of FITC-APTS Conjugates 
FITC (3.5 mg) was dissolved in 500 μL of absolute ethanol and then 
3.6 μL of APTS was added and shaken under dark atmosphere for 18 
hr.  
 
2.2.2. Synthesis of F-silica NPs 
A water in oil reverse microemulsion was prepared by mixing 17.7 
mL of Triton X-100, 18 mL of n-hexanol (co-surfactant), 77 mL of 
cyclohexane (oil phase), and 4 mL of DI water in a 250 mL glass 
container for 15 min at RT. And then FITC-APTS conjugates were 
added. After 10 min of stirring, 1 mL of silica precursor, TEOS and 
1.2 mL of NH4OH were added to the microemulsion solution. After 
30min of stirring, 150 μL of THPMP was added and stirring was 
continued at RT for 20 hr. After 20 hr, the microemulsion system was 
broken by adding 40 mL of ethanol, and F-silica NPs were separated 
from the microemulsion by centrifugation. F-silica NPs were then 








2.3. Surface Modification of F-silica NPs 
 
2.3.1. Preparation of Amine-modified F-silica NPs 
 
To prepare amino group modified F-silica NPs, F-silica NPs were first 
treated with APTS. A 50μL of 5 v/v% APTS was added to1 mL of F-
silica NPs dispersed in ethanol (25 mg/mL). Then, 10 μL of NH4OH 
was added to the mixture. The mixture was stirred for 1 hr at 50 ℃. 
The mixture was then purified by centrifugation (14000 rpm for 30 
min) and decantation(5 times) in NMP. 
 
The amino group of F-silica NPs was coupled with Fmoc-Lys for 
increasing the amino group moiety. To the previously prepared amine 
modified F-silica NPs (1eq.) in NMP, Fmoc-Lys (3 eq.) was coupled 
with HOBt (3 eq.), BOP (3 eq.) and DIEA (3 eq.) in NMP at RT for 2 hr. 
After Fmoc group deprotection with 20 % piperidine in NMP for 10 
min, Fmoc-Lys was coupled again to Lys modified F-silica NPs with 
HOBt (3 eq.), BOP (3 eq.) and DIEA (3 eq.) in NMP. The mixture was 
stirred at RT in 2hr and then purified by centrifugation (14000 rpm for 








2.3.2. Preparation of PEG Modified F-silica NPs 
 
To prepare biocompatible NPs, F-silica NPs functionalized with 
amino groups was react with heterobifunctional PEG (Fmoc-PEG-
COOH) of two different chain lengths (molecular weight of PEG = 
2000 and 10000, respectively). The carboxyl group of Fmoc-NH-
PEG2000 (3 eq.) was coupled to amino groups on F-silica NPs (1eq.) 
with HOBt (3 eq.), BOP (3 eq.) and DIEA (3 eq.) in NMP for 2 hr at RT. 
In another case, Fmoc protected PEG10000 (3 eq.) with active ester 
group was added to 10 mg of amine functionalized F-silica NPs 
dispersed in NMP, followed by addition of DIEA into the mixture. The 
mixture stirred for 5 hr at RT.  
 
After deprotection of Fmoc group, PEGylated F-silica NPs were 
coupled with Fmoc-Lys (3 eq.) with HOBt (3 eq.), BOP (3 eq.) and 
DIEA (3 eq.) in NMP for 2 hr at RT to prepare amino groups on the 
surface of F-silica NPs. The resulting mixture was treated with 20 % of 










2.3.3. NOTA and Water soluble linker Conjugation to F-silica NPs 
 
To the previously prepared amino functionalized F-silica NPs were 
added a mixture of SCN-NOTA (5 eq.) and water-soluble linker sulfo-
SMCC (5 eq.) in PBS buffer solution (pH 7.5) and incubated for 5 hr at 
RT. The isothio cyanate group of 68Ga chelator, p-SCN-Bn-NOTA, was 
then reacted with the amine-functionalized F-silica NPs. On the other 
hand, carboxyl group of sulfo-SMCC was bonded to amine group of F-
silica NPs, which form an amide linkage. And then the mixture was 
purified with unconjugated NOTA and SMCC by centrifugation (14000 













2.3.4. Antibody Conjugation of F-silica NPs 
 
2.3.4.1. Preparation of Half Fragmented Herceptin 
 
A 24 μL of MEA (6 mg/mL) and 50 μL of EDTA (1 mg/mL) in PBS 
buffer (pH 7.5) solution were added into 240 μg of half fragment 
Herceptin in PBS buffer (pH 7.5) solution and then mixture was 
incubated for 90 min at 37 ℃. The  half fragmented Herceptin was 
separated from the resulting mixture using PD-10 desalting column. 
 
2.3.4.2. Herceptin Immobilization on F-silica NPs  
 
For the coupling reaction, the prepared F-silica NPs suspension was 
incubated with the half fragmented Herceptin in PBS buffer ( pH 7.5) 
solution, to achieve a covalent linkage between antibody and the 
nanoparticle system. The incubation was performed for 2 hr at RT 












2.3.5. Labeling with 68Ga 
 
68GaCl3 in 0.1 N hydrochloride acid was obtained from an eluent of 
68Ga/68Ga generator. Radiolabeling of all F-silica NPs (250 μg each) 
was carried out at pH 8 solution with 1 mL of 68GaCl3 and 220 μL of 1 
M sodium acetate (pH 5.6).  Then the reaction mixtures were 
incubated at 37℃ for 30 min. The labeling yield was determined by 
Instant Thin-Layer Chromatography (ITLC-SG) in 0.1 M citric acid. 
The strip was counted using a TLC scanner (AR-2000; Bioscan, USA).  
 
2.3.6. In vitro Cellular Binding 
 
The glass cover slips with breast cancer cell lines (SKBR3+++) on 
them were removed from the culture medium and placed in the 
microscope chamber at 4°C. The cells were covered with DPBS 
solution and surface modified NPs (1mg/mL). After the cells were 
incubated with the NPs for 30 min, the cell images were taken to 









Chapter 3. Results and Discussion 
 
3.1. Synthesis of F-silica NPs 
 
As illustrated in Figure3.1, monodisperse fluorescent dye doped silica 
NPs were synthesized using water in oil reverse microemulsion system. 
Reverse microemulsion methods create thermodynamically stable 
nanodroplet of amphiphilic surfactants. The nano-droplets of water in 
oil phase act as a reactor for discrete particle formation. This method 
has been known to be  efficient for the fabrication of highly  
monodispersed spherical microparticles and for easy surface 
modification.21 It was reported that phosophonate ligand groups on the 
particle’s surface gave highly negative zeta potential so that NPs could 
be  well dispersed.22 Zeta potential of the synthesized F-silica NPs 
was  -20.3 mV and hydrodynamic size was 89.5 nm (The size of F-
silica NPs was 70 nm in diameter as determined by TEM). As expected, 
TEM images showed that  the synthesized F-silica NPs were well 
dispersed and revealed spherical structures having monodispersity. 

























































3.2. Preparation and Characterization of Surface 
Modified F-silica NPs 
 
 
3.2.1. Preparation of Amine-modified F-silica NPs 
 
 
The F-silica NPs were modified with amino groups for the 
conjugation of various molecules. In order to introduce amino group, F-
silica NPs were functionalized with APTS. The amino group is a key 
surface-bound, functional group for the immobilization of chemicals 
and biological molecules. As expected, the more APTS was added into 
F-silica NPs, the less negative charge was developed on the F-silica 
NP’s surface. (1 v/v% APTS, -16.4; 5 v/v% APTS, -13.5). 
For increasing the amino group content, Lysine (Lys) was coupled to 
the amine-modified F-silica NPs twice. Lys has two amino groups. 
Consequently, Lys modified F-silica NPs can have double the amount 
of  amino groups. After Fmoc-Lys was coupled to the amino group of 
F-silica NPs, we quantified the amino groups by Fmoc titration. Table 
3.2 summarizes the results of the amino group quantification, which 
shows that the amount of amino group on Lys modified F-silica NPs 
was actually increased to double (from 70.4 to 146.9 μmol/g) after 
coupling of Lys. Therefore, Lys coupling  turned out to be an efficient 







Table 3.1. Quantifications of Amino Groups on the F-silica NPs  
 
(a) After 1st Lys coupling      (b) After 2nd Lys coupling  
 
 
(a) Quantification after first coupling of Lys 
























Figure 3.3. TEM images of amine modified F-silica NPs ; 










Figure 3.4.  Scheme of surface modification for fabrication 





3.2.2. Preparation of PEG modified F-silica NPs 
 
In general, nanoparticles tend to aggregate through hydrophobic 
interactions or van der Waals forces in an effort to minimize the surface 
energy. In the blood stream, such aggregates can trigger opsonization, a 
process by which a particle is covered with opsonin proteins, thereby 
making it more visible to the mononuclear phagocytic system (MPS), 
such as RES. The phagocytic mechanisms render nanoparticles 
ineffective as theragnostic vehicles by removing them from the 
bloodstream.23 In order to give stealth properties to the nanoparticles, 
one of the most promising method is PEGlyation, modification with 
PEG. It was reported that PEG molecules interfere with the binding of 
opsonin proteins to the nanoparticle surfaces, supporting long 
circulation time, thereby increasing the chance that the nanoparticles 
can effectively target tumor sites.24 
Covalent attachment of one end of a heterobifunctional PEG to the 
amino groups on the F-silica NPs was tried. The configuration and the 
effect of the PEG layer are dependent on the PEG chain length and 
their surface density. We investigated the effect of PEG chain length on 
the resulting NPs’s size, surface charge and 68Ga labeling efficiency of 
NPs. We chose the PEG chains having two different chain lengths (MW 
of 2000 and 10,000, respectively). The amount of loaded PEG2000 on 
the F-silica NPs was 6.5 wt%, which was analyzed by TGA. In the case 














Figure 3.5. TEM images of PEGlyated F-silica NPs, with  












Figure 3.6. The results of TGA Analysis Data of PEG Modified F-silica 















3.2.3. Preparation and Characterization of Multifunctional F-silica 
NPs 
 
Optical imaging with PET has the potential for providing better 
spatial resolution with anatomical information and also improved signal 
sensitivity. For combination of imaging modalities, optical imaging and 
PET, we designed dual modal imaging probe by conjugation of F-silica 
NPs with 68Ga-NOTA.  
PET uses positrons to create γ-rays. The 68Ga is a positron emitting 
molecule with a short half–life (67.6 min). Its short half-life and 
hydrophilic nature are adequate in labeling NPs for rapid clearance for 
PET. The importance of Ga68 for clinical PET has been increased 
recently. 25 In order to introduce 68Ga on the NPs, thiocyanate group 
containing macrocyclic chelating agent NOTA was attached to the 
amino group on PEGylated F-silica NPs. NOTA is a 9-member cyclic 
compound and has been reported to form a highly stable neutral 
complex with Ga3+ ion, which is inert even in 6 N nitric acid.26 
 
 Also, we investigated multifunctional F-silica NP for targeting and 
imaging by employing anti-body. In order to conjugate antibody, a 
water soluble linker, sulfo-SMCC, was coupled to the PEGylated F-
silica NPs. NOTA and sulfo-SMCC were attached to the F-silica NPs 
surface competitively with different mechanism. For specific 





introduced through covalent linkage with F-silica NPs. The maleimide 
moiety can selectively react with sulfhydryl group. To introduce 
sulfhydryl residue on Herceptin, the antibody, which originally contains 
disulfide linkages at the hinge region, was reduced with MEA. The 
sulfhydryl groups produced by this method can couple to the maleimide 
moiety of sulfo-SMCC on F-silica NPs. Therefore, we expect that the 
functionalized F-silica NP is capable of targeting cell, and also 
detectable by optical and PET imaging. Table 3.2 shows the size and 
the zeta potential of these particles. The size of NOTA and SMCC 
modified F-silica NPs were 117.9 nm in diameter, as determined by 
dynamic light scattering (DLS), and the zeta potential was -18.6 mV. 
 In addition, we investigated the effects of PEG chain length and the 
amount of amine moiety (% APTS, v/v) on the resulting particle size 
and surface charge. The results are summarized in Table 3.2, which 
show PEG 2000 modified F-silica NPs is smaller than PEG10000 modified 
F-silica NPs. However, both of them have negatively charged.  
On the other hand, the size of PEG10000 modified F-silica NPs have 
larger size than APTS (1%,v/v) treated one. They also have negative 
charge on the surface. The negative charge on their surface can be 
attributed to a small amount of remnant anionic surfactant used in the 
synthesis of F-silica NPs. 
The net charge of nanoparticles has a pronounced effect on their 
behavior according to the surrounding environment. Furthermore, it can 





in systemic circulation and plays a critical role in the clearance of the 


































3.2.4. Radio-labeling of Surface Modified F-silica NPs 
 
We studied 68Ga labeling efficiency of F-silica NPs for PET imaging. 
The labeling procedure, including purification, was straightforward and 
the products were analyzed by ITLC-SG (Instant Thin Layer 
Chromatography Silica Gel) eluted with 0.1 M citric acid. Free 68Ga did 
not move at all and 68Ga labeled F-silica NPs moved with the eluting 
solvent front. 
We investigated the effects of PEG chain length and the amount of 
amine moiety (% APTS,v/v) on the 68Ga labeling efficiency                                                                                                                                                                                                     
In case of PEG 2000 conjugated F-silica NPs, 68Ga labeling efficiency 
was 77.28 % and then reached to 96.5 % after purification. However, 
Herceptin immobilized ones gave 31.56 % of labeling efficiency. This 
result demonstrates that Herceptin conjugation interferes with NOTA, 
which has decreased Ga labeling efficiency. 
We also tried to figure out the effect of PEG chain length on labeling 
efficiency. When long chain PEG (MW 10,000) was conjugated to F-
silica NPs to improve the solubility and the stability, the resulting F-
silica NPs gave 49.8 % of Ga labeling yield.  
 In that case of APTS (1%,v/v) the ones with modified F-silica NPs, 
which have less amount of amine moiety than using APTS (5%,v/v), 
the labeling efficiency was 89.53 %, and after purification, it was 
increased to 95.93 %. These results demonstrate that APTS(1%,v/v), 





surface modification method for 68Ga labeling. Therefore, 
functionalized F-silica NPs are promising candidate as an efficient PET 






Table 3.3. 68Ga labeling Efficiency of Multifunctional F-silica NPs 
 
precipitated supernatant
APTS(5 v/v%)-(Lys)2-PEG2000-Lys-NOTA/SMCC 77.28 96.51 79.22
APTS(5 v/v%)-(Lys)2-PEG2000-Lys-NOTA/SMCC 31.56
APTS(5 v/v%)-(Lys)2-PEG10000-Lys-NOTA/SMCC 49.84







Table 3.4. The Results of DLS Analysis of Multifunctional F-silica NPs 




















3.2.5. Aggregation Studies of Multifunctional F-silica NPs 
 
There is a natural tendency for the nanoparticles to aggregate 
through hydrophobic interactions or attractive van der Waals forces in 
an effort to minimize the surface energy.  Therefore, it is important to 
keep the nanoparticles suitably dispersed in an aqueous environment 
for bio application. The ideal NPs must fulfill a number of stringent 
requirements: it should be easily dispersible and stable (i.e., resistant 
to aggregation) in a variety of local in-vivo environments and not be 
affected by differences in solvent polarity, ionic strength, pH, or 
temperature. It should exhibit limited nonspecific binding and be 
resistant to reticulo enthothelial system (RES) uptake, and have 
sufficiently long circulation time in the blood stream for long term 
quantitative imaging. To fulfill these terms, we introduced negatively 
charged ligand THPMP on the F-silica NPs and further modified them 
with PEG. The aggregation tendency of multifunctional F-silica NPs at 
different concentrations was observed by using CLSM. Figure 3.7 
shows the images of dispersed multifunctional F-silica NPs. Both of 
PEG2000 and PEG10000 conjugated multifunctional F-silica NPs showed 
well dispersed condition. Aggregation of NPs with biological 
molecules via electrostatic interactions could be a serious issue. 
Therefore, its minimization is essential for sensitive detection of 















Figure 3.7. The CLSM Images of Dispersed Multifunctional F-silica 






3.2.6. In vitro Cellular Binding Study 
 
 
HER2, human epidermal growth factor receptor-2, is a potential target 
as a diagnostic biomarker for breast and ovarian cancers. HER2 over 
expressing breast cancer cells, SK-BR-3, were incubated with the same 
concentration (300 μg/ 30μL) of trastuzumab immobilized F-silica NPs. 
Trastuzumab, a humanized monoclonal antibody, binds to HER2 
receptor specifically. The primary goal of antibody conjugation is to 
introduce a targeting moiety to the F-silica NPs. However, as shown in 
Figure 9, the PEG 2000, or PEG 10000 conjugated F-silica NPs did not 
bind the cell receptor, respectively. These results demonstrate that  
antibody conjugation to a nanoparticle without consideration for the 
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Figure 3.8. Confocal Images of Functionalized F-silica NPs conjugated 
with (a) PEG 2000 (d) PEG 10,000 







The fluorescent dye-doped silica nanoparticles(F-silica NPs) as the 
core material of optical imaging probe were synthesized through 
reverse microemulsion method, which gave highly spherical, 
monodispersed nanoparticles. For fabrication of dualmodal imaging 
probe for PET imaging, we prepared 68Ga conjugated F-silica NPs. 
These particles showed the effective Ga labeling efficiency which 
proved to be a good candidate for efficient PET imaging probe.  
In addition, F-silica NPs were conjugate with PEG and measured the 
effect of PEG chain length on the resulting particle’s size, surface 
charge and 68Ga labeling efficiency. The results showed that APTS 
(1%,v/v) modified F-silica NPs conjugated with PEG 10,000 gave 
effective 68Ga labeling.  
Furthermore, as a targeted imaging agent for breast cancer, we 
prepared Herceptin conjugated F-silica NPs using water soluble liker. 
However, these NPs did not bind to the cell receptor. Further 
improvement of antibody conjugation for effective targeting without 






초    록 
 
나노 입자들은 생체영상분야에서 영상을 위한 표지자나 생물학적 
현상을 영상화할 수 있는 추적자로서 활발하게 이용되고 있다. 
최근에는 생체영상기술의 발전으로 인해 특정 암에 대한 특이적인 
표지자를 추적하여 초기 암 진단과 치료에 이용되고 있다. 
생체영상분야에서 이용되고 있는 다양한 영상기술들은 각각 장점과 
단점을 갖고 있으며, 진단 목적에 따라 다르게 이용되고 있다. 
그러나, 한 가지의 영상 기술만으로는 의학적인 진단에 있어서 
부족함이 따른다. 이를 위해 둘 혹은 세 가지의 영상기술을 
접목하여 더 많은 의학적 정보와 생물학적 현상을 분석하는 노력이 
많이 이루어지고 있다. 이에 본 연구에서는 광학 영상과 핵 
의학영상 기술을 결합하여 생체조직을 손상시키지 않으면서, 기존 
영상 기술보다 민감하게 신호를 얻어 낼 수 있는 나노 표지자의 
개발을 시도하였다. 먼저, 형광이 담지된 실리카 나노 입자를 
합성하여 광학영상을 얻을 수 있도록 설계하였으며, 실리카 나노 
입자 표면에 방사선 동위원소인 68Ga을 표지하여 핵 의학 영상인, 
PET 영상이 가능하도록 하였다. 또한 특정암에 대한 진단이 





이용하여 초기암 진단에 있어서 광학 영상과 핵 의학 영상이 
동시에 가능하도록 설계하였다. 또한 이를 생체 내에서의 이용이 
가능하도록 친수성 고분자인 polyethlyeneglycol(PEG)을 표면에 붙여 
생체적합성을 증가시킬 수 있도록 하였다. 이때 PEG의 분자량을 
2000,10000 으로 달리 도입하여, PEG 사슬 길이에 따른 나노입자의 
사이즈와 표면의 전하의 변화 등 나노 입자의 물성을 확인하였다. 
이러한 과정을 통해 광학 영상과 핵 의학 영상을 동시에 구현할 수 
있는 나노표지 입자의 가능성을 엿볼 수 있었다. 
 
주요어: 다기능성 나노입자, 형광담지실리카나노입자, 특이적 표적을 
위한 영상 표지자, 표면처리, 광학영상, 핵의학영상 
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유기합성실을 떠난 지 벌써 1년이 지나고서야 이렇게 석사과
정을 마치게 되었습니다. 2년 동안 유기합성실에서 너무나 많
은 것을 배우고 느끼고 경험하였습니다. 어렵게 석사과정을 
마무리 한 만큼 주변에서 너무나 많은 도움을 받은 것 같습
니다. 글로나마 감사의 마음을 전합니다. 
 
먼저, 너무나 많은 가르침을 주신 이윤식 교수님. 정말 감사
합니다. 교수님의 제자라는 것이 저에게는 너무나 감사한 일
이고, 큰 행운인 것 같습니다. 전공에 관한 지식뿐만 아니라 
인생을 살아가는 지혜들을 많이 배웠습니다. 너무나도 존경하
는 우리 교수님. 저의 인생에 있어서 교수님을 만날 수 있었
다는 것만으로도 저의 석사과정은 너무 뜻 깊은 시간이었던 
것 같습니다. 항상 건강하시고 앞으로도 멋진 모습, 지금의 
열정적인 교수님 모습, 오래오래 뵐 수 있었으면 좋겠습니다. 
교수님 사랑해요 
 
사랑하는 우리 엄마, 아빠. 내가 살아가는 힘. 딸 공부시키느
라 고생 많이 했지. 힘들어도 내색 안하고 언제나 딸 위해 삶
을 사는 우리 엄마아빠. 앞으로도 좋은 딸 멋진 딸 될게. 이
렇게 잘 키워줘서 너무 감사해요. 사랑해. 
 
우리 실험실 식구들. 나의 사수 멋진 호만 오빠. 오빠 덕분에 
2년 동안 많이 배웠어요. 석사과정 시작과 끝 모두 오빠의 
도움이 없었다면 저의 지금은 없었을 거에요. 항상 열정적인 






나의 멘토 선영언니. 언니는 정말 멋진 여자에요. 석사 하면
서 언니 덕분에 힘들었던 시간들 견딜 수 있었어요. 언니의 
모습을 보면서 많이 본 받고 배우려고 노력했던 것 같아요. 
언니한테는 실망시켜드리기 싫었는데.. 그래도 이렇게 졸업을 
합니다. 언니 너무 감사해요. 사랑해요 히히 
나의 영원한 오빠 형석오빠. 오빠!!! 오빠 덕분에 석사과정 
웃으며 즐기며 무사히 보낼 수 있었어요. 힘들 때마다 오빠가 
곁에서 조언도 해주시고, 좋은 얘기 많이 해주셔서 제가 이렇
게 좋은 회사에 온 것 같아요. 저의 정신적 지주에요 오빠는
^^ 감사해요. 
 그리고 멋진 아기 아빠 홍준오빠 같이 졸업하게 되서 기뻐
요 오빠는 우리 실험실의 감초^^. 항상 묵묵히 챙겨주시고 신
경 써주셨던 재희오빠 세심한 부분 챙겨 주셨던 거 걱정해주
시고 마음 써주셨던 거 너무 감사해요 오빠. 나의 멋진 동기 
오빠들. 나쁜 남자 산오빠. 오빠 때문에 석사 하면서 많이 울
기도 웃기도 한 거 같아. 덕분에 많이 배웠어 고마워^^ 똑똑
한 요한오빠. 오빠를 보면서 석사 하는 동안 자극을 많이 받
은 것 같아. 동기 오빠들. 나름 웃으며 울며 2년 동안 정 많
이 든 것 같아. 고맙고 미안해^^ 
 나의 사랑 새롬이, 진경이. 너희들 없었으면 나의 2년은 어
땠을까. 말로 표현 못할 만큼 너희들의 존재는 너무나 고맙고 
너희들이 내 친구라는 건 너무 큰 복이다. 너희들 때문에 힘
들었던 시간 견딜 수 있었고, 작은 것에도 감사하고 행복해 
하면서 석사과정 할 수 있었어. 너무 고마워. 회사다닌다고 
자주 만나지도 못하고 연락도 잘 못하고 미안해. 졸업할 때까
지 우리 진경이한테는 완전 애물단지다. 그치? 너무 고맙고 
미안해. 우리 새롬이 진경이 너무나 고맙고 사랑해. 영원히 
함께 하자. 





배들과 함께 했던 일년은 너무너무 즐거웠었어요. 선배들 덕
분에 많이 웃으며 보냈던 것 같아요. 감사합니다. 듬직한 준
혁이. 귀염둥이 영오. 너희들과 함께 석사하면서 많이 즐거웠
던 것 같아. 많이 챙겨주지 못해 미안해. 너희들이 많이 도와
주고 함께해줘서 잘 마무리 하는 것 같아. 준혁이 여태 해왔
던 것처럼 앞으로 멋지게 박사과정 잘 해내고. 우리 귀염둥이 
영오. 영오가 항상 누나한테 살갑게 대해주고 잘해줘서 너무 
고마웠어. 앞으로도 멋진 모습 기대할게! 그리고 세원이. 많
은 시간을 함께 하지 
 
세계최고 편광판팀. 먼저, 부족한 저를 우리 팀의 구성원으로 
뽑아주신 우리 위원님. 기회를 주시고 믿고 지켜봐 주셔서 감
사합니다. 앞으로 더 잘할 수 있도록 노력하겠습니다. 우리 
팀 기둥 남과장님. 부족한 저를 항상 응원해주시고 격려해주
셔서, 이렇게 졸업할 수 있게 되었습니다. 앞으로는 더 좋은 
모습 보여드릴 수 있도록 할게요. 지금은 열심히 공부 중이신 
나의 멘토 권과장님. 과장님 덕분에 회사생활 잘 적응한 것 
같아요. 너무나 배울 점이 많은 우리과장님. 과장님께서 항상 
졸업 걱정해주시고 응원해주셔서 많은 힘이 되었습니다. 감사
합니다. 멋진 김과장님. 졸업 때문에 연수 늦게 가느라 민폐
끼치고.. 죄송해요 과장님^^ 제가 과장님 좋아하는 거 아시
져? 저의 정신적 지주 정대리님. 대리님의 조언들 덕분에 너
무 큰 힘이 되었습니다. 졸업 때문에 많이 걱정하면서 일했는
데 대리님이 응원해주셔서 잘 마무리합니다. 앞으로도 잘 부
탁드려요^^ 저의 버팀목 남대리님. 일에서나, 생활에서나 걱
정 많이 해주시고 신경 써주시고 응원해주신 덕분에 이렇게 
졸업할 수 있게 되었어요. 연수 가느라 민폐 끼쳐서 죄송해요 
우리대리님 최고 ^^* 나의 사랑하는 동기 혜민언니, 미린이. 
언니랑 미린이가 곁에 있어 너무나 큰 힘이고 복이야. 너무너





 내사랑 지혜, 지선이. 나 드디어 졸업이다. 너희들과 이 영
광 함께 하고 싶다. 응원해줘서 고마워.  
 
제 인생에 있어 뜻 깊은 2년. 어렵게 석사과정 마무리 하는
만큼 더 소중한 것 같습니다. 주변의 좋은 사람들 덕분에 잘 
마무리 할 수 있었고, 더더욱 갚진 시간이었습니다. 너무 감
사합니다.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
